<?xml version="1.0"?>
<rss version="2.0">
	<channel>
		<title>News for  companies  (in Generics only).</title>
		<link>http://www.lifescience-online.com/</link>
		<description>News Feed Powered by Lifescience-online.com</description>
		<language>en-us</language>
		<pubDate>Wed, 08 Feb 2012 03:56:43 +0100</pubDate>
		<lastBuildDate>Wed, 08 Feb 2012 03:56:43 +0100</lastBuildDate>
		<category>News</category>		

		<image>
			<title>Lifescience-online</title>
			<url>http://rss.lifescience-online.com/images/logo.gif</url>
			<link>http://www.lifescience-online.com/</link>
			<width></width>
			<height></height>
			<description>Lifescience-online</description>
		</image>

		<item>
			<title>Lannett Receives FDA Approval for ANDA Supplement for Phentermine HCL Capsules, 15 mg</title>
			<link>http://www.lifescience-online.com/Lannett_Receives_FDA_Approval_for_ANDA_Supplement_,30794.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/1.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Central Nervous System</dd><br /><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/lannett_co,835.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>LANNETT CO INC</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/PHENTERMINE_HYDROCHLORIDE,10276.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>PHENTERMINE HYDROCHLORIDE</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Mon, 30 Jan 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Lannett Company, Inc. (LCI) Receives FDA Approval for Hydrochlorothiazide Capsules, 12.5 mg</title>
			<link>http://www.lifescience-online.com/Lannett_Company__Inc___LCI__Receives_FDA_Approval_,30747.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/3.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Cardiovascular</dd><br /><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/lannett_co,835.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>LANNETT CO INC</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/HYDROCHLOROTHIAZIDE,9998.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>HYDROCHLOROTHIAZIDE</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Sun, 29 Jan 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>GenVec Inc. (GNVC) Extends Research Collaboration with Global Pharmaceutical</title>
			<link>http://www.lifescience-online.com/GenVec_Inc___GNVC__Extends_Research_Collaboration_,30733.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/0.gif' /></div><dl><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/genvec,681.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>GENVEC INC</u></font></a><br /><a href='http://www.lifescience-online.com/global_pharmaceuticals,15096.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>Global Pharmaceuticals</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Thu, 26 Jan 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Watson Pharmaceuticals, Inc. (WPI) Buys Strides Arcolab Limited&#039; Australia Unit for $396 Million</title>
			<link>http://www.lifescience-online.com/Watson_Pharmaceuticals__Inc___WPI__Buys_Strides_Ar,30702.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/3/0.gif' /></div><dl><dt><b>Category</b> :</dt><dd>Changes and Acquisitions</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/watson_pharmaceuticals,1262.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>WATSON PHARMACEUTICALS INC</u></font></a><br /><a href='http://www.lifescience-online.com/strides_arcolab,13775.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>Strides Arcolab</u></font></a><br /><a href='http://www.lifescience-online.com/ascent_pharmaceuticals,,13873.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>Ascent Pharmaceuticals, Inc</u></font></a><br /><a href='http://www.lifescience-online.com/ascent_pharmahealth,15248.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>ASCENT PHARMAHEALTH LTD</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Mon, 23 Jan 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Trius Earns $5 Million Milestone Payment From Bayer for Successful Completion of First Phase 3 Trial of Tedizolid</title>
			<link>http://www.lifescience-online.com/Trius_Earns__5_Million_Milestone_Payment_From_Baye,30691.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/1.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Anti-Infective</dd><br /><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/bayer_healthcare,5151.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>BAYER HEALTHCARE AG</u></font></a><br /><a href='http://www.lifescience-online.com/trius_therapeutics,9917.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>Trius Therapeutics Inc</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/TEDIZOLID_PHOSPHATE,22388.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>TEDIZOLID PHOSPHATE</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Sun, 22 Jan 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>FDA Advisory Committee Declines to Recommend Approval of Progesterone Vaginal Gel 8% for the Reduction of Risk of Preterm Birth in Women with Short Uterine Cervical Length</title>
			<link>http://www.lifescience-online.com/FDA_Advisory_Committee_Declines_to_Recommend_Appro,30655.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/3.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Endocrine</dd><br /><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/columbia_laboratories,484.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>COLUMBIA LABORATORIES INC</u></font></a><br /><a href='http://www.lifescience-online.com/watson_pharmaceuticals,1262.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>WATSON PHARMACEUTICALS INC</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/PROGESTERONE,2175.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>PROGESTERONE</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Thu, 19 Jan 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Sandoz initiates two more Phase III biosimilar trials, reinforcing long-term global leadership commitment</title>
			<link>http://www.lifescience-online.com/Sandoz_initiates_two_more_Phase_III_biosimilar_tri,30673.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/1.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Oncology</dd><br /><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/sandoz,6628.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>SANDOZ</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/FILGRASTIM,526.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>FILGRASTIM</u></font></a><br /><a href='http://www.lifescience-online.com/PEGFILGRASTIM,538.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>PEGFILGRASTIM</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Wed, 18 Jan 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

	</channel>
</rss>
